CN Patent

CN108367008A — 包含多拉韦林、富马酸替诺福韦二吡呋酯和拉米夫定的药物组合物

Assigned to Merck Sharp and Dohme BV · Expires 2018-08-03 · 8y expired

What this patent protects

本发明涉及包含多拉韦林、富马酸替诺福韦二吡呋酯和拉米夫定的药物组合物。这些组合物可用于治疗HIV感染。还公开了制备所述药物组合物的方法。

USPTO Abstract

本发明涉及包含多拉韦林、富马酸替诺福韦二吡呋酯和拉米夫定的药物组合物。这些组合物可用于治疗HIV感染。还公开了制备所述药物组合物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN108367008A
Jurisdiction
CN
Classification
—
Expires
2018-08-03
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.